Skip to main content
. 2017 Feb 15;8(12):19566–19576. doi: 10.18632/oncotarget.15361

Table 2. Univariate and multivariate analyses of E-cadherin expression in disease-free survival and overall survival.

Variable analysis Disease-Free Survival Overall Survival
HR 95% CI p HR 95% CI p
Univariate N = 125 N = 125
E-cadherin 0.229 0.053–0.991 0.049 0.028 0.001–15.090 0.266
Multivariate N = 125 N = 125
Gender 0.749 0.279–2.008 0.565 0.541 0.111–2.637 0.447
Age 0.281 0.101–0.786 0.016 0.149 0.028–0.786 0.025
Size 0.708 0.209–2.400 0.579 0.505 0.061–4.207 0.528
Stage 1.779 1.007–3.142 0.047 2.165 0.951–4.930 0.066
Necrosis 2.346 0.734–7.500 0.150 1.298 0.250–6.750 0.756
Fuhrman 1.249 0.736–2.118 0.409 1.868 0.841–4.150 0.125
E-cadherin 0.206 0.046–0.928 0.040 0.000 0.000–4.007E205 0.960

The variables were compared in the following ways: Age, ≥ 57 years vs. < 57 years; Gender, male vs. female; E-cadherin expression, positive vs. negative; size, > 5.25 vs. < 5.25; Stage, III–IV vs. I–II; Necrosis, yes vs. no; Fuhrman grade, G3-4 vs. G1-2.